DHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Danaher Corp (DHR) is not a strong buy for a beginner, long-term investor at this time. While the company has shown solid financial performance in Q4 2025 and analysts maintain positive ratings with increased price targets, the technical indicators suggest a bearish trend, and there are no strong proprietary trading signals. Additionally, cautious sentiment from Congress trading data and ongoing shareholder concerns regarding governance weigh negatively. The investor should wait for clearer positive catalysts or a more favorable entry point.
The MACD is negative and contracting (-1.075), RSI is neutral at 32.267, and moving averages are converging, indicating no clear upward momentum. The stock is trading below the pivot level of 217.598, with support at 210.92 and resistance at 224.275. The overall trend appears bearish in the short term.
Analysts have raised price targets consistently, with most maintaining Buy or Outperform ratings. The company reported strong YoY growth in revenue (+4.59%), net income (+10.22%), and EPS (+12.75%) in Q4 2025, signaling solid financial performance. Recovery in life sciences and bioprocessing markets could provide long-term growth opportunities.
Technical indicators suggest a bearish short-term trend. Congress members have sold the stock recently, indicating cautious sentiment. News of potential breaches of fiduciary duties and shareholder governance concerns could weigh on investor confidence. Gross margin dropped by 2.52% YoY in Q4 2025, which may indicate some operational challenges.
In Q4 2025, Danaher reported revenue of $6.838 billion (+4.59% YoY), net income of $1.197 billion (+10.22% YoY), and EPS of $1.68 (+12.75% YoY). However, gross margin declined to 58% (-2.52% YoY), which could indicate cost pressures.
Analysts have raised price targets recently, with the highest target at $275 and a median target around $265. Most analysts maintain Buy or Outperform ratings, citing recovery in key markets and potential upside from M&A activity. However, some caution remains regarding sector rotation and macroeconomic uncertainties.
